Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

MYGN - Myriad Genetics, Inc. Financial Statements | Finranks

Home

/

MYGN

M

Myriad Genetics, Inc. (MYGN)

NMS – Real Time Price. Currency in USD

3.23

+0.01 (0.47%)

At close: Aug 12, 2026, 3:59 PM EDT

3.23

0.00 (0.00%)

After-hours: Aug 12, 2026, 4:15 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

825M

838M

753M

678M

Cost of goods sold

-248M

-252M

-279M

-243M

Gross Profit

577M

585M

474M

435M

Operating expenses (excl. COGS)

-644M

-673M

-619M

-554M

Operating Income

-68M

-88M

-145M

-118M

Non-operating income, total

-327M

-36M

-118M

-22M

Pretax income

-395M

-124M

-262M

-141M

Equity in earnings

0

0

0

0

Taxes

29M

-4M

-1M

29M

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-366M

-127M

-263M

-112M

Discontinued operations

0

0

0

0

Net income

-366M

-127M

-263M

-112M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

707M-31.2%

1.03B-17.6%

1.25B-5.4%

1.32B

Total current assets

333M

298M

314M

275M

Total non-current assets

374M

730M

933M

1.04B

Total liabilities

339M+3.7%

327M-29.5%

463M+7.4%

431M

Total current liabilities

134M

164M

156M

137M

Total non-current liabilities

205M

162M

307M

294M

Total equity

368M

701M

783M

886M

Total liabilities & shareholders' equities

707M

1.03B

1.25B

1.32B

Total debt

210M+49.5%

140M-7.8%

152M+4.9%

145M

Name

2025

2024

2023

2022

Cash from operating activities

2M

-9M

-111M

-107M

Cash from investing activities

-27M

-12M

32M

-78M

Cash from financing activities

64M

-7M

153M

-7M

Free cash flow

-14M+50.2%

-28M+84.1%

-174M-14.3%

-152M